| scholarly article | Q13442814 |
| P50 | author | Andrew I Bell | Q37376473 |
| P2093 | author name string | A B Rickinson | |
| J Desmond | |||
| R J Tierney | |||
| H E Kirby | |||
| J K Nagra | |||
| P2860 | cites work | Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex | Q24324026 |
| A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands | Q24562877 | ||
| Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription | Q29547568 | ||
| Methylation-induced repression--belts, braces, and chromatin | Q29617487 | ||
| Epstein-barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt's lymphoma reflect virus strains prevalent in different geographic areas. | Q33640115 | ||
| The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitive | Q33783746 | ||
| Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines | Q33784685 | ||
| The Epstein-Barr virus promoter initiating B-cell transformation is activated by RFX proteins and the B-cell-specific activator protein BSAP/Pax5 | Q33787243 | ||
| DNA sequence and expression of the B95-8 Epstein-Barr virus genome. | Q34245077 | ||
| Mutually exclusive use of viral promoters in Epstein-Barr virus latently infected lymphocytes | Q34299744 | ||
| The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements. | Q34327455 | ||
| Conservation and progressive methylation of Epstein-Barr viral DNA sequences in transformed cells. | Q35237244 | ||
| The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein | Q35648541 | ||
| Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein | Q35854017 | ||
| oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines. | Q35867579 | ||
| Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial. | Q36555784 | ||
| Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs | Q36564877 | ||
| Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. | Q36637195 | ||
| Methylation of discrete sites within the enhancer region regulates the activity of the Epstein-Barr virus BamHI W promoter in Burkitt lymphoma lines | Q36655826 | ||
| Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5'-flanking region | Q36682729 | ||
| EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus | Q36688330 | ||
| Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes | Q36698199 | ||
| Host-cell-phenotype-dependent control of the BCR2/BWR1 promoter complex regulates the expression of Epstein-Barr virus nuclear antigens 2-6 | Q36808722 | ||
| Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1. | Q36810617 | ||
| A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection. | Q36828303 | ||
| 5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael | Q36829470 | ||
| Prolonged inhibitory effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against replication of Epstein-Barr virus | Q36913920 | ||
| Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines | Q36920279 | ||
| Significant potential secondary structures in the Epstein-Barr virus genome | Q37399426 | ||
| Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection | Q37504372 | ||
| Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site | Q37552683 | ||
| Cellular and viral DNA hypomethylation associated with induction of Epstein-Barr virus lytic cycle | Q37557036 | ||
| Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes | Q37557660 | ||
| Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes | Q37707304 | ||
| CpG methylation within the 5' regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site | Q38338770 | ||
| CpG methylation of the cAMP-responsive enhancer/promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation | Q38344762 | ||
| Specific methylation patterns in two control regions of Epstein-Barr virus latency: the LMP-1-coding upstream regulatory region and an origin of DNA replication (oriP). | Q39579096 | ||
| Differential methylation of Epstein-Barr virus latency promoters facilitates viral persistence in healthy seropositive individuals. | Q39596964 | ||
| Regulation of EBNA gene transcription in lymphoblastoid cell lines: characterization of sequences downstream of BCR2 (Cp). | Q39877574 | ||
| Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell | Q39880077 | ||
| Mapping promoter regions that are hypersensitive to methylation-mediated inhibition of transcription: application of the methylation cassette assay to the Epstein-Barr virus major latency promoter. | Q39880772 | ||
| B-cell lines immortalized with an Epstein-Barr virus mutant lacking the Cp EBNA2 enhancer are biased toward utilization of the oriP-proximal EBNA gene promoter Wp1. | Q40015317 | ||
| Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene | Q40062679 | ||
| Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein. | Q40108807 | ||
| Long-term T-cell-mediated immunity to epstein-barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes | Q40189656 | ||
| Binding sites in mammalian genes and viral gene regulatory regions recognized by methylated DNA-binding protein | Q40525481 | ||
| Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless. | Q40793575 | ||
| The activity of the Epstein-Barr virus BamHI W promoter in B cells is dependent on the binding of CREB/ATF factors | Q40892767 | ||
| Characterisation of regulatory sequences at the Epstein-Barr virus BamHI W promoter | Q40984027 | ||
| Creation of genomic methylation patterns | Q40986760 | ||
| Methylation of the Epstein-Barr virus genome in normal lymphocytes | Q41075320 | ||
| CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's disease | Q41158549 | ||
| Host cell phenotype-dependent methylation patterns of Epstein--Barr virus DNA | Q41678227 | ||
| Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line | Q41729284 | ||
| CpG methylation of viral DNA in EBV-associated tumours | Q41730871 | ||
| The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus | Q42813897 | ||
| Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue | Q44068484 | ||
| Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease | Q44983123 | ||
| Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: molecular analysis of primary tumor tissue. | Q45758095 | ||
| Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa | Q45781476 | ||
| Early events in Epstein-Barr virus infection of human B lymphocytes | Q45855126 | ||
| EBV persistence in memory B cells in vivo. | Q52037383 | ||
| Methylation-dependent and -independent DNA binding of nuclear factor EF-C | Q67915836 | ||
| A methylation-responsive MDBP/RFX site is in the first exon of the collagen alpha2(I) promoter | Q73263524 | ||
| Cytosine methylation of repeated sequences in eukaryotes: the role of DNA pairing | Q77064368 | ||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| P304 | page(s) | 10468-10479 | |
| P577 | publication date | 2000-11-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Methylation of transcription factor binding sites in the Epstein-Barr virus latent cycle promoter Wp coincides with promoter down-regulation during virus-induced B-cell transformation | |
| P478 | volume | 74 |
| Q33640163 | AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome |
| Q34032232 | Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype |
| Q37033176 | Alternatively initiated gene 50/RTA transcripts expressed during murine and human gammaherpesvirus reactivation from latency |
| Q42701290 | Analysis of Epstein-Barr virus-regulated host gene expression changes through primary B-cell outgrowth reveals delayed kinetics of latent membrane protein 1-mediated NF-κB activation |
| Q42244791 | Autorepression of Epstein-Barr virus nuclear antigen 1 expression by inhibition of pre-mRNA processing |
| Q34658852 | Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology. |
| Q38596337 | Chromatin Structure of Epstein-Barr Virus Latent Episomes |
| Q39445333 | Contributions of CTCF and DNA methyltransferases DNMT1 and DNMT3B to Epstein-Barr virus restricted latency |
| Q35571255 | Dna methylation in the immune system |
| Q37596770 | Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus |
| Q34549468 | EBV in Hodgkin Lymphoma |
| Q38667123 | Epigenetic Alterations in Epstein-Barr Virus-Associated Diseases |
| Q36109297 | Epigenetic alterations in gastric carcinogenesis |
| Q34518058 | Epigenetic regulation of varicella-zoster virus open reading frames 62 and 63 in latently infected human trigeminal ganglia |
| Q35021339 | Epigenetics in cancer: implications for early detection and prevention |
| Q35531692 | Epstein-Barr virus BamHI W repeat number limits EBNA2/EBNA-LP coexpression in newly infected B cells and the efficiency of B-cell transformation: a rationale for the multiple W repeats in wild-type virus strains |
| Q26863256 | Epstein-Barr virus and host cell methylation: regulation of latency, replication and virus reactivation |
| Q38321333 | Genome-wide analyses of Zta binding to the Epstein-Barr virus genome reveals interactions in both early and late lytic cycles and an epigenetic switch leading to an altered binding profile |
| Q45722276 | High-resolution methylation analysis and in vivo protein-DNA binding at the promoter of the viral oncogene LMP2A in B cell lines carrying latent Epstein-Barr virus genomes |
| Q34273467 | Host cell-dependent expression of latent Epstein-Barr virus genomes: regulation by DNA methylation |
| Q40552882 | Imprinting of Skin/Inflammation Homing in CD4+ T Cells Is Controlled by DNA Methylation within the Fucosyltransferase 7 Gene. |
| Q39290705 | Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines |
| Q34589844 | Modeling early Epstein-Barr virus infection in Drosophila melanogaster: the BZLF1 protein |
| Q35026045 | Pathogenic roles for Epstein-Barr virus (EBV) gene products in EBV-associated proliferative disorders |
| Q34485302 | Quantitative Studies of Epstein-Barr Virus-Encoded MicroRNAs Provide Novel Insights into Their Regulation |
| Q37146126 | Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases |
| Q38232195 | Role of epigenetics in EBV regulation and pathogenesis |
| Q54981954 | Small molecules capable of activating DNA methylation-repressed genes targeted by the p38 mitogen-activated protein kinase pathway. |
| Q35571278 | Stealth technology: how Epstein-Barr virus utilizes DNA methylation to cloak itself from immune detection. |
| Q36978595 | The B-cell-specific transcription factor and master regulator Pax5 promotes Epstein-Barr virus latency by negatively regulating the viral immediate early protein BZLF1. |
| Q38596339 | The Epigenetic Life Cycle of Epstein-Barr Virus |
| Q33910725 | The Epstein-Barr virus lytic cycle activator Zta interacts with methylated ZRE in the promoter of host target gene egr1. |
| Q28210623 | Transcriptional regulation by the phosphorylation-dependent factor CREB |
| Q34782185 | Transcriptional suppression of in vitro-integrated human immunodeficiency virus type 1 does not correlate with proviral DNA methylation |
| Q34411851 | Unbiased mutagenesis of MHV68 LANA reveals a DNA-binding domain required for LANA function in vitro and in vivo |
| Q45727288 | Unique Epstein–Barr virus (EBV) latent gene expression, EBNA promoter usage and EBNA promoter methylation status in chronic active EBV infection |
| Q39575256 | Valproic acid antagonizes the capacity of other histone deacetylase inhibitors to activate the Epstein-barr virus lytic cycle. |
| Q37683015 | Variable methylation of the Epstein-Barr virus Wp EBNA gene promoter in B-lymphoblastoid cell lines |
| Q35118506 | Viral Genes and Methylation |
| Q40867317 | ViralEpi v1.0: a high-throughput spectrum of viral epigenomic methylation profiles from diverse diseases |
| Q35363296 | trans-Repression of protein expression dependent on the Epstein-Barr virus promoter Wp during latency |
Search more.